Researcher Portfolio

 
   

Malchers, Florian

Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society  

 

Researcher Profile

 
Position: Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society
Researcher ID: https://pure.mpg.de/cone/persons/resource/persons147228

External references

 

Publications

 
 
 : Malchers, F., Dietlein, F., Schöttle, J., Lu, X., Nogova, L., Albus, K., Fernandez-Cuesta, L., Heuckmann, J. M., Gautschi, O., Diebold, J., Plenker, D., Gardizi, M., Er, M. S., Bos, M., Seidel, D., Leenders, F., Richters, A., Peifer, M., Florin, A., Mainkar, P. S., Karre, N., Chandrasekhar, S., George, J., Silling, S., Rauh, D., Zander, T., Ullrich, R. T., Reinhardt, H. C., Ringeisen, F., Buettner, R., Heukamp, L. C., Wolf, J., & Thomas, R. K. (2014). Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discovery, 4(2), 246-257. doi:10.1158/2159-8290.CD-13-0323. [PubMan] : Fernandez-Cuesta, L., Plenker, D., Osada, H., Sun, R., Menon, R., Leenders, F., Ortiz-Cuaran, S., Peifer, M., Bos, M., Daßler, J., Malchers, F., Schöttle, J., Vogel, W., Dahmen, I., Koker, M., Ullrich, R. T., Wright, G. M., Russell, P. A., Wainer, Z., Solomon, B., Brambilla, E., Nagy-Mignotte, H., Moro-Sibilot, D., Brambilla, C. G., Lantuejoul, S., Altmüller, J., Becker, C., Nürnberg, P., Heuckmann, J. M., Stoelben, E., Petersen, I., Clement, J. H., Sänger, J., Muscarella, L. A., la Torre, A., Fazio, V. M., Lahortiga, I., Perera, T., Ogata, S., Parade, M., Brehmer, D., Vingrom, M., Heukamp, L. C., Buettner, R., Zander, T., Wolf, J., Perner, S., Ansen, S., Haas, S. A., Yatabe, Y., & Thomas, R. K. (2014). CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discovery, 4(4), 415-422. doi:10.1158/2159-8290.CD-13-0633. [PubMan] : Sos, M. L., Dietlein, F., Peifer, M., Schöttle, J., Balke-Want, H., Müller, C., Koker, M., Richters, A., Heynck, S., Malchers, F., Heuckmann, J. M., Seidel, D., Eyers, P. A., Ullrich, R. T., Antonchik, A. P., Vintonyak, V. V., Schneider, P. M., Ninomiya, T., Waldmann, H. H., Büttner, R., Rauh, D., Heukamp, L., & Thomas, R. K. (2012). A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America, 109(42), 17034-17039. doi:10.1073/pnas.1207310109. [PubMan] : Heuckmann, J. M., Balke-Want, H., Malchers, F., Peifer, M., Sos, M. L., Koker, M., Meder, L., Lovly, C. M., Heukamp, L. C., Pao, W., Küppers, R., & Thomas, R. K. (2012). Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants. Clinical Cancer Research, 18(17), 4682-4690. doi:10.1158/1078-0432.CCR-11-3260. [PubMan]